Top

Clinical Research in Cardiology

Published in:

01-06-2018 | Original Paper

Impact of generalized anxiety disorder (GAD) on prehospital delay of acute myocardial infarction patients. Findings from the multicenter MEDEA study

Authors: X. Y. Fang, D. Spieler, L. Albarqouni, J. Ronel, K-H. Ladwig

Published in: Clinical Research in Cardiology | Issue 6/2018

Abstract

Background

Anxiety has been identified as a cardiac risk factor. However, less is known about the impact of generalized anxiety disorder (GAD) on prehospital delay during an acute myocardial infarction (AMI). This study assessed the impact of GAD on prehospital delay and delay related cognition and behavior.

Methods

Data were from the cross-sectional Munich examination of delay in patients experiencing acute myocardial infarction (MEDEA) study with a total of 619 ST-elevated myocardial infarction (STEMI) patients. Data on socio-demographic, clinical and psycho-behavioral characteristics were collected at bedside. The outcome was assessed with the Generalized Anxiety Disorder scale (GAD-7). A GAD-7 score greater than or equal to 10 indicates general anxiety disorder.

Results

A total of 11.47% (n = 71) MI patients suffered from GAD. GAD was associated with decreased odds of delay compared to patients without GAD (OR 0.58, 95% CI 0.35–0.96), which was more significant in women (112 vs. 238 min, p = 0.02) than in men (150 vs. 198 min, p = 0.38). GAD was highly correlated with acute anxiety (p = 0.004) and fear of death (p = 0.005). Nevertheless, the effect remained significant after controlling for these two covariates. GAD patients were more likely to perceive a higher cardiovascular risk (OR 2.56, 95% CI 1.37–4.76) in 6 months before MI, which leads to the higher likelihood of making self-decision to go to the hospital (OR 2.68, 95% CI 1.48–4.85) in the acute phase. However, GAD was also highly associated with impaired psychological well-being, stress and fatigue (p < 0.0001).

Conclusions

In AMI patients, GAD was independently associated with less prehospital delay, but led to an impaired psychological state.

Grupe DW, Nitschke JB (2013) Uncertainty and anticipation in anxiety: an integrated neurobiological and psychological perspective. Nat Rev Neurosci 14(7):488–501. https://doi.org/10.1038/nrn3524 CrossRefPubMedPubMedCentral

Tovote P, Fadok JP, Luthi A (2015) Neuronal circuits for fear and anxiety. Nat Rev Neurosci 16(6):317–331. https://doi.org/10.1038/nrn3945 CrossRefPubMed

Moser DK (2007) “The rust of life”: impact of anxiety on cardiac patients. Am J Crit Care 16(4):361–369PubMedPubMedCentral

Celano CM, Millstein RA, Bedoya CA, Healy BC, Roest AM, Huffman JC (2015) Association between anxiety and mortality in patients with coronary artery disease: A meta-analysis. Am Heart J 170(6):1105–1115. https://doi.org/10.1016/j.ahj.2015.09.013 CrossRefPubMedPubMedCentral

American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th edn. American Psychiatric Publishing, Arlington, VACrossRef

WHO (1992) The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. World Health Organization, Geneva

Hoge EA, Ivkovic A, Fricchione GL (2012) Generalized anxiety disorder: diagnosis and treatment. BMJ 345:e7500. https://doi.org/10.1136/bmj.e7500 CrossRefPubMed

Wittchen HU (2002) Generalized anxiety disorder: prevalence, burden, and cost to society. Depress Anxiety 16(4):162–171. https://doi.org/10.1002/da.10065 CrossRefPubMed

Tully PJ, Cosh SM, Baumeister H (2014) The anxious heart in whose mind? A systematic review and meta-regression of factors associated with anxiety disorder diagnosis, treatment and morbidity risk in coronary heart disease. J Psychosom Res 77(6):439–448. https://doi.org/10.1016/j.jpsychores.2014.10.001 CrossRefPubMed

10.

Blumenthal JA, Feger BJ, Smith PJ, Watkins LL, Jiang W, Davidson J, Hoffman BM, Ashworth M, Mabe SK, Babyak MA, Kraus WE, Hinderliter A, Sherwood A (2016) Treatment of anxiety in patients with coronary heart disease: rationale and design of the UNderstanding the benefits of exercise and escitalopram in anxious patients WIth coroNary heart Disease (UNWIND) randomized clinical trial. Am Heart J 176:53–62. https://doi.org/10.1016/j.ahj.2016.03.003 CrossRefPubMedPubMedCentral

11.

Emdin CA, Odutayo A, Wong CX, Tran J, Hsiao AJ, Hunn BH (2016) Meta-analysis of anxiety as a risk factor for cardiovascular disease. Am J Cardiol 118(4):511–519. https://doi.org/10.1016/j.amjcard.2016.05.041 CrossRefPubMed

12.

Perez-Pinar M, Ayerbe L, Gonzalez E, Mathur R, Foguet-Boreu Q, Ayis S (2017) Anxiety disorders and risk of stroke: a systematic review and meta-analysis. Eur Psychiatry 41:102–108. https://doi.org/10.1016/j.eurpsy.2016.11.004 CrossRefPubMed

13.

Martens EJ, de Jonge P, Na B, Cohen BE, Lett H, Whooley MA (2010) Scared to death? Generalized anxiety disorder and cardiovascular events in patients with stable coronary heart disease: the heart and soul study. Arch Gen Psychiatry 67(7):750–758. https://doi.org/10.1001/archgenpsychiatry.2010.74 CrossRefPubMed

14.

Parker G, Hyett M, Hadzi-Pavlovic D, Brotchie H, Walsh W (2011) GAD is good? Generalized anxiety disorder predicts a superior five-year outcome following an acute coronary syndrome. Psychiatry Res 188(3):383–389. https://doi.org/10.1016/j.psychres.2011.05.018 CrossRefPubMed

15.

Herrmann C, Brand-Driehorst S, Buss U, Ruger U (2000) Effects of anxiety and depression on 5-year mortality in 5,057 patients referred for exercise testing. J Psychosom Res 48(4–5):455–462. https://doi.org/10.1016/S0022-3999(99)00086-0 CrossRefPubMed

16.

Meyer T, Herrrmann-Lingen C, Chavanon ML, Nolte K, Pasedach CA, Binder L, Pieske B, Hasenfuss G, Wachter R, Edelmann F (2015) Higher plasma levels of MR-pro-atrial natriuretic peptide are linked to less anxiety: results from the observational DIAST-CHF study. Clin Res Cardiol 104(7):574–581. https://doi.org/10.1007/s00392-015-0820-9 CrossRefPubMed

17.

Kobe J, Hucklenbroich K, Geisendorfer N, Bettin M, Frommeyer G, Reinke F, Dechering D, Burgmer M, Eckardt L (2017) Posttraumatic stress and quality of life with the totally subcutaneous compared to conventional cardioverter-defibrillator systems. Clin Res Cardiol 106(5):317–321. https://doi.org/10.1007/s00392-016-1055-0 CrossRefPubMed

18.

O’Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso JE, Tracy CM, Woo YJ, Zhao DX (2013) 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 127(4):529–555. https://doi.org/10.1161/CIR.0b013e3182742c84 CrossRefPubMed

19.

Ladwig KH, Meisinger C, Hymer H, Wolf K, Heier M, von Scheidt W, Kuch B (2011) Sex and age specific time patterns and long term time trends of pre-hospital delay of patients presenting with acute ST-segment elevation myocardial infarction. Int J Cardiol 152(3):350–355. https://doi.org/10.1016/j.ijcard.2010.08.003 CrossRefPubMed

20.

Spitzer RL, Kroenke K, Williams JB, Lowe B (2006) A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 166(10):1092–1097. https://doi.org/10.1001/archinte.166.10.1092 CrossRefPubMed

21.

Olsen LR, Jensen DV, Noerholm V, Martiny K, Bech P (2003) The internal and external validity of the major depression inventory in measuring severity of depressive states. Psychol Med 33(2):351–356CrossRefPubMed

22.

Birket-Smith M, Rasmussen A (2008) Screening for mental disorders in cardiology outpatients. Nord J Psychiatry 62(2):147–150. https://doi.org/10.1080/08039480801983562 CrossRefPubMed

23.

Bech P (2004) Measuring the dimension of psychological general well-being by the WHO-5. QoL Newslett 32:15–16

24.

Kop WJ, Gottdiener JS, Tangen CM, Fried LP, McBurnie MA, Walston J, Newman A, Hirsch C, Tracy RP (2002) Inflammation and coagulation factors in persons > 65 years of age with symptoms of depression but without evidence of myocardial ischemia. Am J Cardiol 89(4):419–424. https://doi.org/10.1016/S0002-9149(01)02264-0 CrossRefPubMed

25.

Burnett RE, Blumenthal JA, Mark DB, Leimberger JD, Califf RM (1995) Distinguishing between early and late responders to symptoms of acute myocardial infarction. Am J Cardiol 75(15):1019–1022CrossRefPubMed

26.

von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP (2008) The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 61(4):344–349. https://doi.org/10.1016/j.jclinepi.2007.11.008 CrossRef

27.

Moser DK, McKinley S, Dracup K, Chung ML (2005) Gender differences in reasons patients delay in seeking treatment for acute myocardial infarction symptoms. Patient Educ Couns 56(1):45–54. https://doi.org/10.1016/j.pec.2003.11.011 CrossRefPubMed

28.

Khraim FM, Carey MG (2009) Predictors of pre-hospital delay among patients with acute myocardial infarction. Patient Educ Couns 75(2):155–161. https://doi.org/10.1016/j.pec.2008.09.019 CrossRefPubMed

29.

Abed MA, Khalil AA, Moser DK (2015) The contribution of symptom incongruence to prehospital delay for acute myocardial infarction symptoms among Jordanian patients. Res Nurs Health 38(3):213–221. https://doi.org/10.1002/nur.21658 CrossRefPubMed

30.

Albarqouni L, Rothe AV, Ronel J, Meinertz T, Ladwig KH (2016) Frequency and covariates of fear of death during myocardial infarction and its impact on prehospital delay: findings from the multicentre MEDEA study. Clin Res Cardiol 105(2):135–144. https://doi.org/10.1007/s00392-015-0895-3 CrossRefPubMed

31.

Dubayova T, van Dijk JP, Nagyova I, Rosenberger J, Havlikova E, Gdovinova Z, Middel B, Groothoff JW (2010) The impact of the intensity of fear on patient’s delay regarding health care seeking behavior: a systematic review. Int J Public Health 55(5):459–468. https://doi.org/10.1007/s00038-010-0149-0 CrossRefPubMedPubMedCentral

32.

Guerchicoff A, Brener SJ, Maehara A, Witzenbichler B, Fahy M, Xu K, Gersh BJ, Mehran R, Gibson CM, Stone GW (2014) Impact of delay to reperfusion on reperfusion success, infarct size, and clinical outcomes in patients with ST-segment elevation myocardial infarction: the INFUSE-AMI trial (INFUSE-Anterior Myocardial Infarction). JACC Cardiovasc Interv 7(7):733–740. https://doi.org/10.1016/j.jcin.2014.01.166 CrossRefPubMed

33.

Tyrer P, Baldwin D (2006) Generalised anxiety disorder. Lancet 368(9553):2156–2166. https://doi.org/10.1016/s0140-6736(06)69865-6 CrossRefPubMed

34.

Bunz M, Lenski D, Wedegartner S, Ukena C, Karbach J, Bohm M, Kindermann I (2016) Heart-focused anxiety in patients with chronic heart failure before implantation of an implantable cardioverter defibrillator: baseline findings of the Anxiety-CHF study. Clin Res Cardiol 105(3):216–224. https://doi.org/10.1007/s00392-015-0909-1 CrossRefPubMed

35.

Kroenke K, Spitzer RL, Williams JB, Monahan PO, Lowe B (2007) Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med 146(5):317–325CrossRefPubMed

Title: Impact of generalized anxiety disorder (GAD) on prehospital delay of acute myocardial infarction patients. Findings from the multicenter MEDEA study
Authors: X. Y. Fang
D. Spieler
L. Albarqouni
J. Ronel
K-H. Ladwig
Publication date: 01-06-2018
Publisher: Springer Berlin Heidelberg
Published in: Clinical Research in Cardiology / Issue 6/2018
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI: https://doi.org/10.1007/s00392-018-1208-4

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

At a glance: The STEP trials

Springer Medicine

Impact of generalized anxiety disorder (GAD) on prehospital delay of acute myocardial infarction patients. Findings from the multicenter MEDEA study

Abstract

Background

Methods

Results

Conclusions

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The STEP trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 6/2018

Temporal changes in outcomes of women and men undergoing percutaneous coronary intervention for chronic total occlusion: 2005–2013

The 6MWT as a prognostic tool in pulmonary arterial hypertension: results from the COMPERA registry

Very late erosion of Amplatzer occluder device resulting in Cardiac tamponade after 15 years

Risk marker profiles in patients treated with percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy

Revision: prognostic impact of baseline glucose levels in acute myocardial infarction complicated by cardiogenic shock—a substudy of the IABP-SHOCK II-trial

The clinical relevance of drug–drug interaction between co-trimoxazole and sacubitril/valsartan treatment in a heart failure patient: a case report and overview of mechanisms and management in clinical practice

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page